Figure 3. B. glabrata embryos exposed to piplartine at the blastula stage.

A) Immediately following exposure to 1.2 µg/ml piplartine, B) during the 7 day observation period after exposure to 1.0 µg/ml piplartine (1- dead, 2 - normal, 3 – malformed).